Not on the assumption that shortage-era permissions continue. Prescribing a compounded product does not independently establish that its manufacture, distribution and dispensing qualify for federal exemptions. FDA’s retrieved policy page states that semaglutide and tirzepatide are not on its shortage list or 503B bulks list. (fda.gov)
Relevant milestones include:
| Date | Verified development | Procurement implication |
|---|---|---|
| December 19, 2024 | FDA issued a new determination resolving the tirzepatide injection shortage | Do not rely on an earlier shortage-era justification. (fda.gov) |
| February 21, 2025 | FDA determined the semaglutide injection shortage was resolved | Review any continuing arrangement against post-shortage requirements. (fda.gov) |
| April 30, 2026 | FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list | A proposal is not a final determination; nor is it permission to compound. (fda.gov) |
For an actual proposal, obtain a dated explanation of the statutory pathway, exact formulation, ingredient eligibility and applicable copying restrictions. Require counsel to distinguish a statutory exemption from enforcement discretion.
Unresolved in this review: the live shortage-database entries could not be retrieved. Recheck them immediately before approving any arrangement whose justification depends on shortage status.
Explore the table row by row
A working view of the research
December 19, 2024
- Verified development
- FDA issued a new determination resolving the tirzepatide injection shortage
- Procurement implication
- Do not rely on an earlier shortage-era justification. (fda.gov)
Sources cited on this page
- fda.gov · Source 1 ↗https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
- fda.gov · Source 2 ↗https://www.fda.gov/media/185526/download?attachment=&utm_source=openai
- fda.gov · Source 3 ↗https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list?utm_source=openai